A fusion peptide regulating stat3 phosphorylation and its application
A technology of phosphorylation and fusion of peptides, applied in the field of biomedicine, can solve problems such as application limitations, and achieve the effects of good transmembrane activity, inhibition of inflammatory response, and inhibition of activation
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0039] 1. Chemically synthesized fusion peptide
[0040] The fusion peptide TAT-KIR was synthesized by Shanghai Chueptide Biotechnology Co., Ltd., wherein the KIR polypeptide sequence is: L-K-T-F-S-S-K-S-E-Y-Q-L, and the TAT sequence is: R-K-K-R-R-Q-R-R-R. The fusion peptide is N-terminally labeled with fluorescein isothiocyanate (FITC).
[0041] In order to reduce the molecular weight of the target peptide and increase the membrane-penetrating efficiency of the membrane-penetrating peptide, a part of the sequence truncated from the SOCS3 protein was selected as the KIR. After screening, the KIR similar to the JAK activation loop of the JAK substrate can be used as a false substrate to prevent the combination of the JAK substrate and JAK, thereby inhibiting the activity of JAK, thereby inhibiting the activation of the JAK / STAT3 signaling pathway and inhibiting the inflammatory response .
[0042] 2. Detection of fusion peptide transmembrane transport efficiency
[0043] PC12...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com